Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.
Br J Surg. 1995 Oct;82(10):1414-20. doi: 10.1002/bjs.1800821039.
Br J Surg. 1995.
PMID: 7489182
Clinical Trial.